Search
forResearch 10 of 287
- Vaniqa--eflornithine 13.9% cream.
- Human Dermal Safety Studies with Eflornithine HCl 13.9% Cream (Vaniqa™), a Novel Treatment for Excessive Facial Hair
- Hair disorders update: Alopecia to hirsutism
- The evaluation and management of hirsutism*1
- Randomized, double‐blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair
- Methods in hair research: how to objectively distinguish between anagen and catagen in human hair follicle organ culture
- A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women
- Medical treatment of hirsutism
- Guidance for the management of hirsutism
- Best Practice Options for Hair Removal in Patients with Unwanted Facial Hair Using Combination Therapy with Laser: Guidelines Drawn up by an Expert Working Group
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →